Southern Sichuan HIV Cohort Study Protocol (NCT07519538) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Southern Sichuan HIV Cohort Study Protocol
China10 participantsStarted 2026-04-03
Plain-language summary
Multi-source data-integrated HIV cohort in four cities of southern Sichuan, China: a mixed retrospective-prospective study protocol.
Who can participate
Age range18 Years – 85 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* People living with HIV (PLWH) or AIDS patients who are registered and diagnosed at the participating research centers in Luzhou, Zigong, Neijiang, or Yibin, China
* Key assessment information (clinical, laboratory, or follow-up data) obtainable during the study period
* Traceable medical treatment or follow-up records within the retrospective time window (1 January 2019 to 31 December 2025)
* Able to understand and complete the questionnaire and provide written informed consent (for the prospective component)
* Residing or visiting within the four southern Sichuan cities, or continuously managed at the local research centers
Exclusion Criteria:
* Missing key information that cannot be verified or supplemented from original records
* Unable to complete the questionnaire and no alternative data collection method available
* Obviously inconsistent or untrustworthy data that cannot be confirmed after verification
* Not suitable for inclusion under ethical and compliance requirements (e.g., unable to provide consent without a legally authorized representative when required)